Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience.
Grisham, Rachel Nicole
Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience. [electronic resource] - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Jun 2012 - 807-11 p. digital
Publication Type: Journal Article
1525-1438
10.1097/IGC.0b013e31824a33a2 doi
Adenocarcinoma, Clear Cell--drug therapy
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--therapeutic use
CA-125 Antigen--metabolism
Cystadenocarcinoma, Serous--drug therapy
Deoxycytidine--analogs & derivatives
Endometrial Neoplasms--drug therapy
Female
Follow-Up Studies
Humans
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Neoplasm Staging
Prognosis
Retrospective Studies
Survival Rate
Gemcitabine
Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience. [electronic resource] - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Jun 2012 - 807-11 p. digital
Publication Type: Journal Article
1525-1438
10.1097/IGC.0b013e31824a33a2 doi
Adenocarcinoma, Clear Cell--drug therapy
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--therapeutic use
CA-125 Antigen--metabolism
Cystadenocarcinoma, Serous--drug therapy
Deoxycytidine--analogs & derivatives
Endometrial Neoplasms--drug therapy
Female
Follow-Up Studies
Humans
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Neoplasm Staging
Prognosis
Retrospective Studies
Survival Rate
Gemcitabine